ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
5,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
7,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
8,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
15,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
16,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
17,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
18,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
19,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
19,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
20,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
20,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
22,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
24,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
24,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
26,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
26,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
27,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
27,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
28,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
28,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
